“Allocents direct billing SDK showing an embedded native payment sheet with Apple Pay inside a mobile app, enabling developers to bypass Apple’s 30% App Store commission with a 5% + 50¢ per transaction fee.” San Francisco-based Allocents has launched a direct billing SDK for iOS and Android developers that bypasses Apple’s 30% App Store commission …
Singapore-Based Creative For More Establishes New York Presence to Support U.S.-to-Asia Brand Expansion
“Geraldine Pang, Founder of Creative For More” SINGAPORE/NEW YORK – April 16, 2026 – Creative For More (C4M), a cross-border digital marketing consultancy headquartered in Singapore, has officially established its U.S. presence with a New York-based entity registered as a Delaware LLC. The move strengthens the agency’s ability to serve American brands expanding into Southeast …
Autism Spectrum Disorder Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
DelveInsight’s “Autism Spectrum Disorder Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Autism Spectrum Disorder pipeline landscape. It covers the Autism Spectrum Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Autism Spectrum Disorder Pipeline Therapeutics assessment by product type, stage, route …
Ulcerative Colitis Clinical Trial Pipeline Expands as 70+ Companies Driving Innovation in the Therapeutics | DelveInsight
DelveInsight’s “Ulcerative Colitis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ulcerative Colitis therapeutics assessment by product type, stage, route of administration, and molecule type. …
Fabry Disease Market Estimated at USD 1.7 Billion in 2024, Reports DelveInsight
“Fabry Disease Market” Leading organizations engaged in the Fabry disease domain include Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, GREENOVATION BIOTECH GMBH, Shire, Takeda, Amicus Therapeutics, Protalix, uniQure, Codexis, MP6 Therapeutics, CellGenTech, and several others. During 2024, the United States dominated the Fabry disease therapeutics landscape, capturing nearly 52% …
Continue reading “Fabry Disease Market Estimated at USD 1.7 Billion in 2024, Reports DelveInsight”
Hunter Syndrome Market to Surpass USD 1.2 Billion by 2036 | 15+ Emerging Therapies and 10+ Companies Driving Innovation, analyses DelveInsight
“Hunter Syndrome Market” The major companies operating in the Hunter Syndrome space include Homology Medicine, Denali Therapeutics, Regenxbio, Takeda, JCR Pharmaceuticals, GC Pharma, Sangamo Therapeutics, ArmaGen, and others. In 2023, the United States represented the largest share of the Hunter Syndrome market across the 7MM, with approximately 500 prevalent cases. Available treatment options include enzyme …
Platinum-Resistant Ovarian Cancer Market Outlook 2034: Rising Incidence and Robust Pipeline Drive Future Opportunities, analyses DelveInsight
“Platinum-Resistant Ovarian Cancer Market” Key Platinum-Resistant Ovarian Cancer Companies are Corcept Therapeutics, Advenchen Laboratories, Regeneron Pharmaceuticals, Laekna Therapeutics, and others. The platinum-resistant ovarian cancer market is witnessing growth driven by significant unmet clinical needs, as a large proportion of patients relapse following initial platinum-based therapies, increasing the requirement for innovative second- and later-line treatment options. …
Crohn’s Disease Treatment Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight
DelveInsight’s, “Crohn’s Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn’s Disease pipeline landscape. It covers the Crohn’s Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Crohn’s Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. …
Mantle Cell Lymphoma Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight
DelveInsight’s “Mantle Cell Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Mantle Cell Lymphoma pipeline landscape. It covers the Mantle Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Mantle Cell Lymphoma therapeutics assessment by product type, stage, route of …
Silicone Adhesives & Sealants Market Forecast to 2028 with 5.91% CAGR, Reaching USD 9.67 Billion
“Silicone Adhesives & Sealants Market” Explore the Silicone adhesives & sealants market (2024–2028) with mordor intelligence. Get in-depth insights on market size, share, revenue, segments, key drivers, latest trends, and growth opportunities shaping the future of sustainable construction. Silicone Adhesives & Sealants Market Overview The Silicone adhesives and sealants market continues to show steady expansion, …